Integra LifeSciences Holdings (IART) is a publicly traded Healthcare sector company. As of September 4, 2026, IART trades at $16.50 with a market cap of $1.31B and a P/E ratio of -184.17. IART moved +0.82% today. Year to date, IART is +36.89%; over the trailing twelve months it is +5.05%. Its 52-week range spans $8.70 to $27.13. Analyst consensus is neutral with an average price target of $19.29. Rallies surfaces IART's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for IART, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $16.50 |
| Market Cap | $1.31B |
| P/E Ratio | -184.17 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.13 |
| 52-Week Low | $8.70 |
| Volume | 144.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.65B |
| Net Income | $-7.24M |
| Gross Margin | 52.47% |
8 analysts cover IART: 0 strong buy, 1 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $19.29.